These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18191942

  • 1. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.
    Biocca S, Filesi I, Mango R, Maggiore L, Baldini F, Vecchione L, Viola A, Citro G, Federici G, Romeo F, Novelli G.
    J Mol Cell Cardiol; 2008 Mar; 44(3):561-70. PubMed ID: 18191942
    [Abstract] [Full Text] [Related]

  • 2. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.
    Mango R, Biocca S, del Vecchio F, Clementi F, Sangiuolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli C, Lauro R, Mehta JL, Romeo F, Novelli G.
    Circ Res; 2005 Jul 22; 97(2):152-8. PubMed ID: 15976314
    [Abstract] [Full Text] [Related]

  • 3. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
    Mehta JL.
    Can J Cardiol; 2004 Aug 22; 20 Suppl B():32B-36B. PubMed ID: 15309203
    [Abstract] [Full Text] [Related]

  • 4. Lectin-like oxidized low-density lipoprotein receptor (LOX-1) functions as an oligomer and oligomerization is dependent on receptor density.
    Matsunaga S, Xie Q, Kumano M, Niimi S, Sekizawa K, Sakakibara Y, Komba S, Machida S.
    Exp Cell Res; 2007 Apr 01; 313(6):1203-14. PubMed ID: 17306253
    [Abstract] [Full Text] [Related]

  • 5. Oligomerization is required for the activity of recombinant soluble LOX-1.
    Cao W, Calabro V, Root A, Yan G, Lam K, Olland S, Sanford J, Robak A, Zollner R, Lu Z, Ait-Zahra M, Agostinelli R, Tchistiakova L, Gill D, Harnish D, Paulsen J, Shih HH.
    FEBS J; 2009 Sep 01; 276(17):4909-20. PubMed ID: 19664054
    [Abstract] [Full Text] [Related]

  • 6. Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage.
    Kakinuma T, Yasuda T, Nakagawa T, Hiramitsu T, Akiyoshi M, Akagi M, Sawamura T, Nakamura T.
    Arthritis Rheum; 2004 Nov 01; 50(11):3495-503. PubMed ID: 15529384
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of LOXIN Protects Endothelial Progenitor Cells From Apoptosis Induced by Oxidized Low Density Lipoprotein.
    Veas C, Jara C, Willis ND, Pérez-Contreras K, Gutierrez N, Toledo J, Fernandez P, Radojkovic C, Zuñiga FA, Escudero C, Aguayo C.
    J Cardiovasc Pharmacol; 2016 Apr 01; 67(4):326-35. PubMed ID: 26771151
    [Abstract] [Full Text] [Related]

  • 8. LOX-1/LOXIN: the yin/yang of atheroscleorosis.
    Mango R, Predazzi IM, Romeo F, Novelli G.
    Cardiovasc Drugs Ther; 2011 Oct 01; 25(5):489-94. PubMed ID: 21904818
    [Abstract] [Full Text] [Related]

  • 9. Loxin Reduced the Inflammatory Response in the Liver and the Aortic Fatty Streak Formation in Mice Fed with a High-Fat Diet.
    Reyes C, Nova-Lamperti E, Duran-Sandoval D, Rojas D, Gajardo J, Guzman-Gutierrez E, Bustos-Ruiz C, Ormazábal V, Zúñiga FA, Escudero C, Aguayo C.
    Int J Mol Sci; 2022 Jun 30; 23(13):. PubMed ID: 35806336
    [Abstract] [Full Text] [Related]

  • 10. High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL receptor (LOX-1).
    Hoshikawa H, Sawamura T, Kakutani M, Aoyama T, Nakamura T, Masaki T.
    Biochem Biophys Res Commun; 1998 Apr 28; 245(3):841-6. PubMed ID: 9588202
    [Abstract] [Full Text] [Related]

  • 11. LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.
    Rizzacasa B, Morini E, Pucci S, Murdocca M, Novelli G, Amati F.
    Int J Mol Sci; 2017 Jan 29; 18(2):. PubMed ID: 28146073
    [Abstract] [Full Text] [Related]

  • 12. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?
    Chen XP, Zhang TT, Du GH.
    Cardiovasc Drug Rev; 2007 Jan 29; 25(2):146-61. PubMed ID: 17614937
    [Abstract] [Full Text] [Related]

  • 13. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
    Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G.
    Cardiovasc Res; 2006 Jan 29; 69(1):36-45. PubMed ID: 16324688
    [Abstract] [Full Text] [Related]

  • 14. LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells.
    Sugimoto K, Ishibashi T, Sawamura T, Inoue N, Kamioka M, Uekita H, Ohkawara H, Sakamoto T, Sakamoto N, Okamoto Y, Takuwa Y, Kakino A, Fujita Y, Tanaka T, Teramoto T, Maruyama Y, Takeishi Y.
    Cardiovasc Res; 2009 Oct 01; 84(1):127-36. PubMed ID: 19487339
    [Abstract] [Full Text] [Related]

  • 15. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.
    Chen X, Zhang T, Du G.
    Cell Biochem Funct; 2008 Oct 01; 26(7):760-70. PubMed ID: 18636435
    [Abstract] [Full Text] [Related]

  • 16. Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).
    Ishigaki T, Ohki I, Utsunomiya-Tate N, Tate SI.
    J Biochem; 2007 Jun 01; 141(6):855-66. PubMed ID: 17416594
    [Abstract] [Full Text] [Related]

  • 17. Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma.
    Kanata S, Akagi M, Nishimura S, Hayakawa S, Yoshida K, Sawamura T, Munakata H, Hamanishi C.
    Biochem Biophys Res Commun; 2006 Sep 29; 348(3):1003-10. PubMed ID: 16904074
    [Abstract] [Full Text] [Related]

  • 18. Essential role of cytoplasmic sequences for cell-surface sorting of the lectin-like oxidized LDL receptor-1 (LOX-1).
    Chen M, Sawamura T.
    J Mol Cell Cardiol; 2005 Sep 29; 39(3):553-61. PubMed ID: 15935375
    [Abstract] [Full Text] [Related]

  • 19. Chlamydia pneumoniae infection enhances lectin-like oxidized low-density lipoprotein receptor (LOX-1) expression on human endothelial cells.
    Yoshida T, Koide N, Mori I, Ito H, Yokochi T.
    FEMS Microbiol Lett; 2006 Jul 29; 260(1):17-22. PubMed ID: 16790013
    [Abstract] [Full Text] [Related]

  • 20. Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption.
    Matarazzo S, Quitadamo MC, Mango R, Ciccone S, Novelli G, Biocca S.
    Mol Pharmacol; 2012 Aug 29; 82(2):246-54. PubMed ID: 22570368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.